Last reviewed · How we verify

Split dose of methadone

Wake Forest University Health Sciences · FDA-approved active Small molecule

Split-dose methadone divides the daily methadone dose into multiple administrations to optimize plasma levels and reduce peak-trough fluctuations.

Split-dose methadone divides the daily methadone dose into multiple administrations to optimize plasma levels and reduce peak-trough fluctuations. Used for Opioid use disorder maintenance treatment, Chronic pain management.

At a glance

Generic nameSplit dose of methadone
SponsorWake Forest University Health Sciences
Drug classOpioid agonist
TargetMu opioid receptor
ModalitySmall molecule
Therapeutic areaAddiction Medicine / Pain Management
PhaseFDA-approved

Mechanism of action

Methadone is a synthetic opioid agonist that binds to mu opioid receptors in the central nervous system. By administering methadone in split doses rather than a single daily dose, the regimen aims to maintain more stable opioid receptor occupancy throughout the day, potentially reducing withdrawal symptoms and cravings while minimizing side effects associated with high peak concentrations.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: